Skip to content

Effect of topical Atorvastatin on hand eczema

Evaluating the effect of topical Atorvastatin as adjuvant therapy in treatment of hand eczema

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017070922965N10
Enrollment
70
Registered
2017-07-18
Start date
2017-08-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatitis. Other atopic dermatitis

Interventions

Intervention 1: Intervention group: Betamethason ointment plus atorvastatin 5% cream 2 times per day for 10 days. Intervention 2: Control group: Betamethason ointment plus placebo atorvastatin 5% crea
Treatment - Drugs
Intervention group: Betamethason ointment plus atorvastatin 5% cream 2 times per day for 10 days
Control group: Betamethason ointment plus placebo atorvastatin 5% cream 2 times per day for 10 days

Sponsors

Vice chancellor for research, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Age between 18-65 years old; Moderate to severe eczema; Patients who less than 25% of their skin is involved; Discountinue of glucocorticoid agents 4 weeks prior to the investigation; Discountinue of antipuritis agents 1 week prior to the investigation Exclusion criteria: Age less than 18 years old; Patients with inflammatory skin disease; Pregnant woman

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Eczema. Timepoint: 5 and 10 days following of treatment. Method of measurement: Hand eczema index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mehrpooya

School of Pharmacy, Hamedan University of Medical Sciences

m_mehrpooya2003@yahoo.com+98 81 3838 1594

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 17, 2026